XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Settlement of convertible senior notes
Adjustment
Common Stock
Class A Common Stock 
Common Stock
Class A Common Stock 
Conversion of Class B common stock to Class A common stock
Common Stock
Class A Common Stock 
Settlement of convertible senior notes
Common Stock
Class B Common Stock 
Common Stock
Class B Common Stock 
Conversion of Class B common stock to Class A common stock
Additional Paid-in Capital
Additional Paid-in Capital
Settlement of convertible senior notes
Additional Paid-in Capital
Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Adjustment
Beginning balance (in shares) at Jan. 31, 2022       149,624     6,978              
Beginning balance at Jan. 31, 2022 $ 5,922     $ 0     $ 0   $ 7,750     $ (12) $ (1,816)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock, net (in shares)       4,040     451              
Issuance of common stock, net 52               52          
Conversion of convertible securities (in shares)         129 356   (129)            
Settlement of convertible senior notes   $ 17               $ 17        
Proceeds from hedges related to convertible senior notes (in shares)       (140)                    
Stock-based compensation 683               683          
Other comprehensive loss (income) (21)                     (21)    
Net income (loss) (815)                       (815)  
Ending balance (in shares) at Jan. 31, 2023       154,009     7,300              
Ending balance at Jan. 31, 2023 5,466   $ (372) $ 0     $ 0   7,974   $ (528) (33) (2,475) $ 156
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock, net (in shares)       5,850                    
Issuance of common stock, net 67               67          
Conversion of convertible securities (in shares)         9     (9)            
Proceeds from hedges related to convertible senior notes (in shares)       (33)                    
Stock-based compensation 690               690          
Settlement of warrants (7)               (7)          
Other comprehensive loss (income) 27                     27    
Net income (loss) (355)                       (355)  
Ending balance (in shares) at Jan. 31, 2024       159,835     7,291              
Ending balance at Jan. 31, 2024 5,888     $ 0     $ 0   8,724     (6) (2,830)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock, net (in shares)       5,710     623              
Issuance of common stock, net 74               74          
Taxes withheld related to net share settlement of equity awards (149)               (149)          
Conversion of convertible securities (in shares)         105     (105)            
Stock-based compensation 570               570          
Other comprehensive loss (income) (6)                     (6)    
Net income (loss) 28                       28  
Ending balance (in shares) at Jan. 31, 2025       165,650     7,809              
Ending balance at Jan. 31, 2025 $ 6,405     $ 0     $ 0   $ 9,219     $ (12) $ (2,802)